Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy
| | | |

Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy

On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…